Healthcare costs among patients with chronic constipation: A retrospective claims analysis in a commercially insured population

Journal of Medical Economics

Volumn 17, Issue 2, 2014, Pages 148-158

  Cai, Qian ^a   Buono, Jessica L ^b   Spalding, William M ^c   Sarocco, Phil ^d   Tan, Hiangkiat ^a   Stephenson, Judith J ^a   Carson, Robyn T ^b   Doshi, Jalpa A ^d  

^a HEALTHCORE INC   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

^c Ironwood Pharmaceuticals   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic constipation; Economic burden; Healthcare resource utilization; Incremental healthcare costs

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; BOOTSTRAPPING; COMORBIDITY; CONSTIPATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT CARE; PHYSICIAN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CONSTIPATION; FEMALE; HEALTH SERVICES; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84892713830     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2013.860375     Document Type: Article

References (22)

1. Johanson JF. Review of the treatment options for chronic constipation. Med Gen Med 2007;9:25
2. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91
3. Higgins PD, Johnanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750-9
4. Chang L. Impact of chronic constipation and IBS. Adv Stud Med 2006;6: S49-57
5. Lembo AJ, Camilleri M. Chronic constipation. N Engl J Med 2003;349: 1360-8
6. World Gastroenterology Organisation Global Guidelines. Coping with common GI symptoms in the community-A global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort. Milwaukee, WI, USA: World Gastroenterology Organisation. 2013. http://www.world gastroenterology.org/ assets/export/userfiles/2013-FINAL-Common%20GI% 20Symptoms%20-long.pdf. Accessed August 2, 2013
7. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl 1):S1-4
8. Nyrop KA, Palsson OS, Levey RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhea and functional abdominal pain. Aliment Pharmacol Ther 2007;26:237-48
9. Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct costs associated with constipation in women. Aliment Pharmacol Ther 2011;33:251-60
10. Mitra D, Davis KL, Baran RW. All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome. Postgrad Med 2011;123:122-32
11. Segel JE. Cost of illness studies-A primer. Research Triangle Park, NC, USA: RTI International. 2006. http://www.amcp.org/WorkArea/Download Asset.aspx?id12960. Accessed February 28, 2013
12. Sun SX, DiBonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci 2011;56:2688-95
13. Akobundu E, Ju J, Blatt L, et al. Cost-of-illness studies: a review of current methods. Pharmacoeconomics 2006;24:869-90
14. Leider HL, Dhaliwal J, Davis EJ, et al. Healthcare costs and nonadherence among chronic opioid users. Am J Manag Care 2011;17:32-40.
15. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27
16. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24: 465-88
17. Glick H, Doshi J. Applications of statistical considerations in health economic evaluation. Short course presented at: International Society for Pharmacoeconomics and Outcomes Research 16th Annual International Meeting; May 22, 2011; Baltimore, MD
18. Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostat 2005;6:93-109
19. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9
20. Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache 2008;48:553-63
21. Barnett SB, Nurmagambetoy TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011;127:145-52
22. Sullivan PW, Ghushchyan VH, Slejko JF, et al. The burden of adult asthma in the United States: Evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011;127:363-9